InsidersTradesSigma
Ascelia Pharma AB Stock: price and insider trades · Finland · FIN-FSA
Track the Ascelia Pharma AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Ascelia Pharma AB has logged 1 reports. Market capitalisation: €393.3m. The latest transaction was disclosed on 23 September 2025 (Purchase). Among the most active insiders: Peter Benson. Every trade is free.
1
Insider Decl.
0
Thresholds
€4,840
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ascelia Pharma AB Strong Buy (bullish), based on 4 analysts. Average price target: SEK 5.60.
35Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 September 2025
Declarations1 total
15,000 shares@ €0.32270.0012% mcap100.0% of flowAktieFI:A003S559-1
Ideal exit: 20 Jun 2026 (T+270)
1 of 1 declaration